Scientists have verified the inhibitory effect of lysozyme on tumors through tumor cell mixing, peritumoral and intratumoral treatment, systemic injection, oral treatment, indirect administration, or combination with other drugs (Sava et al., 1989; Khan et al., 2019). This evidence concerns the gene LYZ and neoplasm.